Drug Fix: US FDA Adcomm Schedule, CMS And Drug Importation, Missed User Fee Goals

Release Date:

Pink Sheet reporters and editors discuss the nearly wide open 2024 FDA advisory committee calendar, CMS’s impact on Florida’s drug importation plan, and the FDA’s many missed user fee goals in 2023.

More On These Topics From The Pink Sheet
The Sudden Stop In US FDA Advisory Committees: https://pink.citeline.com/PS149641/The-Sudden-Stop-In-US-FDA-Advisory-Committees

Drug Importation And Medicaid: Trump Era Guidance Likely Disincentivizes Use: https://pink.citeline.com/PS149635/Drug-Importation-And-Medicaid-Trump-Era-Guidance-
Likely-Disincentivizes-Use

US FDA’s Missed User Fee Goals Spiked In 2023 – And Not Just Because Of COVID-19: https://pink.citeline.com/PS149629/US-FDAs-Missed-User-Fee-Goals-Spiked-In-2023--And-Not-Just-Because-Of-COVID-19

Drug Fix: US FDA Adcomm Schedule, CMS And Drug Importation, Missed User Fee Goals

Title
Drug Fix: US FDA Adcomm Schedule, CMS And Drug Importation, Missed User Fee Goals
Copyright
Release Date

flashback